100
Participants
Start Date
March 5, 2017
Primary Completion Date
March 4, 2018
Study Completion Date
June 4, 2018
Patients receiving Sof/Vel (Epclusa) and Navigation services
Implementing HCV treatment in the jails using FDA-approved medications and continuing there treatment in the community if they are released during their treatment regimen.
Jail Health Services, San Francisco
Collaborators (1)
University of California, San Francisco
OTHER
San Francisco Study Center
OTHER
Gilead Sciences
INDUSTRY
San Francisco Department of Public Health
OTHER_GOV